We are live on ! Find out more
TMO icon

Thermo Fisher Scientific
TMO

1,458 hedge funds and large institutions have $78B invested in Thermo Fisher Scientific in 2018 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 471 increasing their positions, 595 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 75

8% more funds holding in top 10

Funds holding in top 10: 118 → 128 (+10)

8% more funds holding

Funds holding: 1,351 → 1,458 (+107)

6% more call options, than puts

Call options by funds: $337M | Put options by funds: $318M

0.19% less ownership

Funds ownership: 88.3% → 88.12% (-0.19%)

10% less capital invested

Capital invested by funds: $86.9B → $78B (-$8.91B)

21% less repeat investments, than reductions

Existing positions increased: 471 | Existing positions reduced: 595

Holders
1,458
Holders Change
+107
Holders Change %
+7.92%
% of All Funds
32.48%
Holding in Top 10
128
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+8.47%
% of All Funds
2.85%
New
195
Increased
471
Reduced
595
Closed
75
Calls
$337M
Puts
$318M
Net Calls
+$18.6M
Net Calls Change
+$46.3M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$510M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$364M
3
JP Morgan Chase
JP Morgan Chase
New York
+$307M
4
BlackRock
BlackRock
New York
+$221M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$189M

Top Sellers

Rank Fund Capital Flow
1
Eagle Capital Management (New York)
Eagle Capital Management (New York)
New York
-$762M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$496M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$312M
4
Capital International Investors
Capital International Investors
California
-$268M
5
GCM
Glenview Capital Management
New York
-$242M
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
876
Ally Financial
Michigan
$1.12M +$1.17M +5,000 New
PGAM
877
Princeton Global Asset Management
New Jersey
$1.11M +$1.17M +4,980 New
CIM
878
CenturyLink Investment Management
Colorado
$1.09M +$294K +1,252 +35%
RCG
879
Rock Creek Group
District of Columbia
$1.08M +$1.13M +4,836 New
DI
880
DAGCO Inc
Ohio
$1.07M +$1.12M +4,775 New
LNB
881
Ledyard National Bank
$1.07M +$43.4K +185 +4%
BS
882
Bessemer Securities
New York
$1.06M +$1.12M +4,755 New
SGAM
883
Steinberg Global Asset Management
Florida
$1.06M – – –
CI
884
Cavalier Investments
Georgia
$1.06M +$1.11M +4,740 New
FHA
885
Flagship Harbor Advisors
Massachusetts
$1.06M -$143K -608 -11%
AT
886
Arden Trust
Delaware
$1.06M -$122K -518 -10%
TWI
887
Thomas White International
Illinois
$1.04M – – –
JDR
888
Jay D. Rosenbaum
$1.03M -$8.21K -35 -0.8%
ACS
889
Archford Capital Strategies
Illinois
$1.03M +$10.1K +43 +0.9%
NAM
890
North American Management
Massachusetts
$1.02M – – –
SCI
891
Stableford Capital II
Arizona
$1.02M -$131K -557 -11%
SAM
892
Sectoral Asset Management
Quebec, Canada
$1.02M – – –
CT
893
Cambridge Trust
Massachusetts
$1.01M -$17.6K -75 -2%
SCM
894
Sterling Capital Management
North Carolina
$1.01M -$855K -3,645 -45%
SCM
895
Southport Capital Management
Tennessee
$1.01M +$12.4K +53 +1%
WA
896
Wheatland Advisors
Pennsylvania
$1.01M -$164K -700 -13%
CCM
897
Cullen Capital Management
New York
$1.01M – – –
LW
898
Linscomb Wealth
Texas
$1M +$20.4K +87 +2%
TF
899
Tompkins Financial
New York
$1M -$122K -520 -10%
CIC
900
Crawford Investment Counsel
Georgia
$996K – – –
34 35
36
37 38

TMO Hedge Fund Activity: Q4 2018 in Review

1,458 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2018, worth a combined $78B — down 10% from $86.9B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new TMO positions and 75 closed out — a net gain of 120 holders — while 471 added to existing stakes and 595 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $510M. The largest seller was Eagle Capital Management (New York), cutting an estimated $762M.

  • 1,458 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2018, up from 1,351 in Q3 2018.
  • Funds reported $78B of Thermo Fisher Scientific stock for Q4 2018, down 10% quarter-over-quarter.
  • 195 funds opened new Thermo Fisher Scientific positions in Q4 2018 and 75 closed out, a net change of +120 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2018 was Fidelity Investments, an estimated $510M added.
  • The largest Thermo Fisher Scientific seller in Q4 2018 was Eagle Capital Management (New York), an estimated $762M sold.

Based on aggregated 13F filings for Q4 2018.